Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101 crores in Q4FY23.
Jubilant Pharmova Q4FY23; Reported Losses

Tags: Radiopharma
Related Post
- Life Insurance Corporation of India Q4FY25; 38% rise in Profits
Life Insurance Corporation (LIC) is the largest insurance provider company in India. It has a…
-
Laurus Labs Ltd Q4FY25; 211% rise in Profits
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global…
-
Kansai Nerolac Paints Ltd Q4FY25; 11% fall in Profits
Having started its operations in 1920 as Gahagan Paints & Varnish in Mumbai, Kansai Nerolac…